CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
12.11
+0.39 (3.33%)
Dec 20, 2024, 4:00 PM EST - Market closed
CVRx, Inc. Employees
CVRx, Inc. had 200 employees as of December 31, 2023. The number of employees increased by 40 or 25.00% compared to the previous year.
Employees
200
Change (1Y)
40
Growth (1Y)
25.00%
Revenue / Employee
$236,275
Profits / Employee
-$292,385
Market Cap
293.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 200 | 40 | 25.00% |
| Dec 31, 2022 | 160 | 51 | 46.79% |
| Dec 31, 2021 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 1,029 |
| Cerus | 637 |
| Rigel Pharmaceuticals | 147 |
| 4D Molecular Therapeutics | 147 |
| Nyxoah | 147 |
| Sanara MedTech | 108 |
| Aclaris Therapeutics | 91 |
| Sera Prognostics | 57 |
CVRX News
- 4 weeks ago - CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - CVRx: Impressive Top-Line Growth Seems Priced In - Seeking Alpha
- 7 weeks ago - CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CVRx announces new CPT® Category I codes for Barostim - GlobeNewsWire
- 2 months ago - CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024 - GlobeNewsWire
- 3 months ago - CVRx Announces Appointment of Two New Board Members - GlobeNewsWire
- 4 months ago - CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - GlobeNewsWire
- 4 months ago - The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join - Accesswire